Saccomano Nicholas A's Form 4 filing
OnKure Therapeutics, Inc. (OKUR) · filed Apr 8, 2025
- Accession no.
- 0001415889-25-010419
- Filed
- Apr 8, 2025
- Trade date
- Apr 4-7, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.57K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saccomano Nicholas ACIK 0001609284 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | Class A Common Stock | SSaleDisposed | −358 | $3.33 | −$1,192.14 | 4,198 | Direct | |
| Apr 7, 2025 | Class A Common Stock | SSaleDisposed | −516 | $2.67 | −$1,377.72 | 3,682 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.